Caprioli Joseph, Zeyen Thierry
Jules Stein Eye Institute, Los Angeles, CA 90095, USA.
J Glaucoma. 2009 Aug;18(6 Suppl):S1-21. doi: 10.1097/IJG.0b013e3181aff461.
The International Glaucoma Think Tank II brought together glaucoma clinicians and researchers from all over the world to discuss current practices in glaucoma diagnosis and management, and the neurobiology of glaucoma. The meeting focused on several themes, including rates of deterioration in glaucoma patients, mechanisms of optic nerve damage, and implications for treatment. Issues such as how to measure and integrate progression information into clinical practice, screening protocols, or trials were discussed, as were promising new technologies and limitations of currently available measurement tools. Clinical applications for genetic testing were considered. Study of the neurobiology of glaucoma continues to inform our understanding of underlying degenerative processes, as well as to introduce possibilities for early detection or prevention. Many questions regarding glaucoma pathophysiology and best treatment practices remain unanswered, but with continued research and discussion, we will advance our understanding of this disease and ensure that patients receive optimal care.
第二届国际青光眼智囊团会议汇聚了来自世界各地的青光眼临床医生和研究人员，共同探讨青光眼诊断与管理的现行做法以及青光眼的神经生物学。会议聚焦于几个主题，包括青光眼患者的病情恶化率、视神经损伤机制及其对治疗的影响。会上讨论了如何衡量病情进展信息并将其整合到临床实践、筛查方案或试验中，还讨论了有前景的新技术以及现有测量工具的局限性。会议还考虑了基因检测的临床应用。对青光眼神经生物学的研究不断加深我们对潜在退行性过程的理解，也为早期检测或预防带来了可能性。关于青光眼病理生理学和最佳治疗方法仍有许多问题未得到解答，但通过持续的研究和讨论，我们将增进对这种疾病的理解，并确保患者得到最佳治疗。
